A detailed history of Life Plan Financial, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Life Plan Financial, LLC holds 5,483 shares of GILD stock, worth $507,561. This represents 0.39% of its overall portfolio holdings.

Number of Shares
5,483
Previous 6,373 13.97%
Holding current value
$507,561
Previous $437 Million 5.13%
% of portfolio
0.39%
Previous 0.4%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$66.59 - $83.99 $59,265 - $74,751
-890 Reduced 13.97%
5,483 $460 Million
Q2 2024

Jul 30, 2024

SELL
$63.15 - $72.88 $25,386 - $29,297
-402 Reduced 5.93%
6,373 $437 Million
Q1 2024

Apr 30, 2024

BUY
$71.58 - $87.29 $302,282 - $368,625
4,223 Added 165.48%
6,775 $496 Million
Q4 2023

Jan 30, 2024

BUY
$73.27 - $83.09 $186,985 - $212,045
2,552 New
2,552 $207 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Life Plan Financial, LLC Portfolio

Follow Life Plan Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Life Plan Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Life Plan Financial, LLC with notifications on news.